You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Regimen
Published Date: 25 Feb 2026
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen, and Cycle Frequency sections

Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen, and Cycle Frequency sections

Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen, and Cycle Frequency sections

Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Neoadjuvant, Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen, and Cycle Frequency sections

Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Gynecologic, 
Cervix
Intent: Adjuvant, Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, Drug Regimen, and Cycle Frequency sections

Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, and Drug Administration/Special Precautions sections

Feb 2026
Regimen
Published Date: 25 Feb 2026
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications, Adverse Effects, and Drug Administration/Special Precautions sections

Feb 2026
Drug

Published Date: 25 Feb 2026

Revision Summary:


Drug Monograph: Updated Administration and Supplementary Public Funding sections

Feb 2026
Regimen
Published Date: 24 Feb 2026
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Intent: Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Feb 2026
Regimen
Published Date: 24 Feb 2026
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Intent: Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Feb 2026
Regimen
Published Date: 24 Feb 2026
Cancer Type:
Head and Neck, 
Nasopharynx
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Feb 2026

Pages